513
Views
15
CrossRef citations to date
0
Altmetric
Reviews

Neutrons are forever! Historical perspectives

Pages 957-984 | Received 20 Nov 2018, Accepted 08 Jan 2019, Published online: 13 Feb 2019

References

  • Abratt R. 2012. Neutron radiotherapy: Abratt reply. S Afr Med J. 102:270–271.
  • Aghamohammadi SZ, Goodhead DT, Savage JRK. 1989. Production of chromosome aberrations, micronuclei, and sister-chromatid exchanges by 24-keV epithermal neutrons in human Go lymphocytes. Mut Res. 211:225–230.
  • Ainsworth EJ. 1991. Neutrons revisited. Radiat Res. 128:S2–S3.
  • Ali F, Atanackovic J, Boyer C, Festarini A, Kildea J, Paterson LC, Rogge R, Stuart M, Richardson RB. 2018. Dosimetric and microdosimetric analyses for blood exposed to reactor-derived thermal neutrons. J Radiol Prot. 38:1037–1052.
  • Alpen EL, Baum SJ. 1959. Autologous bone-marrow implantation after fast neutron irradiation of dogs. Radiat Res. 11:383–389.
  • Anderson RM, Marsden SJ, Wright EG, Kadhim M, Goodhead DT, Griffin CS. 2000. Complex chromosome aberrations in peripheral blood lymphocytes as a potential biomarker of exposure to high-LET alpha-particles. Int J Radiat Biol. 76:31–42.
  • Anderson RM, Stevens DL, Goodhead DT. 2002. M-FISH analysis shows that complex chromosome aberrations induced by alpha -particle tracks are cumulative products of localized rearrangements. Proc Natl Acad Sci USA. 99:12167–12172.
  • Asbury A, Ojemann R, Nielsen S, Sweet W. 1972. Neuropathological study of fourteen cases of malignant brain tumor treated by boron-10 slow neutron capture radiation. J Neuropathol Exp Neurol. 31:278–303.
  • Attix FH. 2004. Introduction to radiological physics and radiation dosimetry. Weinheim: Wiley. Chapter 16, Neutron interactions and dosimetry; p. 463–505.
  • Barber R, Plumb MA, Boulton E, Roux I, Dubrova YE. 2002. Elevated mutation rates in the germ line of first- and second-generation offspring of irradiated male mice. Proc Natl Acad Sci USA. 99:6877–6882.
  • Barendsen GW. 1964. Impairment of the proliferative capacity of human cells in culture by α-particles with different linear-energy transfer. Int J Radiat Biol. 8:453–466.
  • Barker CA, Postow MA. 2014. Combinations of radiation therapy and immunotherapy for melanoma: a review of clinical outcomes. Int J Radiat Oncol Biol Phys. 88:986–997.
  • Barth RF, Zhang Z, Liu T. 2018. A realistic appraisal of boron neutron capture therapy as a cancer treatment modality. Cancer Commun (Lond). 38:36.
  • Bender MA, Gooch PC. 1962. Persistent chromosome aberrations in irradiated human subjects. Radiat Res. 16:44–53.
  • Berger MJ, Coursey JS, Zucker MA, Chang J. 2017. ESTAR, PSTAR, and ASTAR: computer programs for calculating stopping-power and range tables for electrons, protons, and helium ions (version 2.0.1). Gaithersburg (MD): National Institute of Standards and Technology; [accessed 2018 Nov 15]. https://physics.nist.gov/PhysRefData/Star/Text/PSTAR.html.
  • Berry RJ, Bance DA, Barnes DWH, Cox R, Goodhead DT, Sansom JM, Thacker J. 1977. High energy fast neutrons from the Harwell variable energy cyclotron. II. Biologic studies in mammalian systems. Am J Roentgenol. 129:717–724.
  • Bewley DK. 1968. Calculated LET distributions of fast neutrons. Radiat Res. 34:437–445.
  • Bond VP, Carter RE, Robertson JS, Seymour PH, Hechter HH. 1956. The effects of total-body fast neutron irradiation in dogs. Radiat Res. 4:139–153.
  • Broustas CG, Harken AD, Garty G, Amundson SA. 2018. Identification of differentially expressed genes and pathways in mice exposed to mixed field neutron/photon radiation. BMC Genom. 19:504.
  • Broustas CG, Xu Y, Harken AD, Chowdhury M, Garty G, Amundson SA. 2017. Impact of neutron exposure on global gene expression in a human peripheral blood model. Radiat Res. 187:443–450.
  • Broustas CG, Xu Y, Harken AD, Garty G, Amundson SA. 2017. Comparison of gene expression response to neutron and x-ray irradiation using mouse blood. BMC Genomics. 18:2.
  • Brustad T. 1962. Heavy ions and some aspects of their use in molecular and cellular radiobiology. Adv Biol Med Phys. 8:161–224.
  • Cary LH, Ngudiankama BF, Salber RE, Ledney GD, Whitnall MH. 2012. Efficacy of radiation countermeasures depends on radiation quality. Radiat Res. 177:663–765.
  • Castro JR, Saunders WM, Tobias CA, Chen GT, Curtis S, Lyman JT, Collier JM, Pitluck S, Woodruff KA, Blakely EA, et al. 1982. Treatment of cancer with heavy charged particles. Int J Radiat Oncol Biol Phys. 8:2191–2198.
  • Catterall M. 1972. Clinical experience with fast neutrons. Proc R Soc Med. 65:839–843.
  • Catterall M. 1974. The treatment of advanced cancer by fast neutrons from the Medical Research Council's cyclotron at Hammersmith Hospital, London. Europ J Cancer. 10:343–347.
  • Chadwick J. 1932. Possible existence of a neutron. Nature. 129:312.
  • Chichester DL. 2009. Production and application of neutrons using particle accelerators. Report INL/EXT-09-17312. Idaho: Idaho National Laboratory.
  • Cirrone GAP, Manti L, Marganone D, Petringa G, Giuffrida L, Minapoli A, Picciotto A, Russo G, Cammarata F, Pisciotta P. 2017. First experimental proof of proton boron capture therapy (PBCT) to enhance proton therapy effectiveness. Sci Rep. 8:1141.
  • Colvett RD, Rossi HH, Krishnaswamy V. 1972. Dose distributions around a californium-252 needle. Phys Med Biol. 17:356–364.
  • Conger AD, Giles NH. 1950. The cytogenetic effect of slow neutrons. Genetics. 35:397–419.
  • Cox R, Thacker J, Goodhead DT, Munson RJ. 1977. Mutation and inactivation of mammalian cells by various ionising radiations. Nature. 267:425–427.
  • Cucinotta FA. 2015. A new approach to reduce uncertainties in space radiation cancer risk predictions. PLoS One. 10:e0120717.
  • Cucinotta FA, Durante M. 2006. Cancer risk from exposure to galactic cosmic rays: implications for space exploration by human beings. Lancet Oncol. 7:431–435.
  • Dale RG, Jones B. 1999. The assessment of RBE effects using the concept of biologically effective dose. Int J Radiat Oncol Biol Phys. 43:639–645.
  • Daniels EW, Vogel HH. 1959. Effects of nonirradiated protoplasm on recovery of amoebae exposed to supralethal doses of fission neutrons. Radiat Res. 5:584–596.
  • Denekamp J. 1994. Neutron radiobiology revisited. Acta Oncol. 33:233–240.
  • Dodge J. 2015. Space radiation: CSU studies risks for astronauts going to Mars. [accessed 2018 December 20]. https://source.colostate.edu/space-radiation-csu-studies-the-risks-for-astronauts-journeying-to-mars/.
  • Drosg M, 1999. Monoenergetic neutron production by two body reactions in the energy range from 0.0001 to 500 MeV (Overview), Technical. report. Vienna: Inst Exper Phys, University of Vienna; [Accessed 2018 Oct 18]. https://homepage.univie.ac.at/Manfred.Drosg/drosg99.pdf.
  • Dubrova YE, Plumb M, Brown J, Boulton E, Goodhead D, Jeffreys AJ. 2000. Induction of minisatellite mutations in the mouse germline by low-dose chronic exposure to gamma-radiation and fission neutrons. Mutat Res. 453:17–24.
  • Durante M, Formenti SC. 2018. Radiation-induced chromosomal aberrations and immunotherapy: micronuclei, cytosolic DNA, and interferon-production pathway. Front Oncol. 8:192.
  • Durante M, Paganetti H. 2016. Nuclear physics in particle therapy: a review. Rep Prog Phys. 79:096702.
  • Endo S, Stevens DL, Bonner P, Hill MA, Nikjoo H, Dalla Vecchia M, Komatsu K, Hoshi M, Goodhead DT. 1999. Reduction of the gamma-ray component from 252Cf fission neutron source–optimization for biological irradiations and comparison with MCNP code. Phys Med Biol. 44:1207–1218.
  • Evans HJ, Neary GJ, Williamson FS. 1959. The relative biological efficiency of single doses of fast neutrons and gamma-rays on Vicia faba roots and the effect of oxygen Part II. Chromosome damage: the production of micronuclei. Int J Radiat Biol. 1:216–229.
  • Farr LE, Robertson JS, Stickley E. 1954. Physics and physiology of neutron-capture therapy. Proc Natl Acad Sci USA. 40:1087–1093.
  • Feather N. 1960. A history of neutrons and nuclei. Part 1. Contemp Phys. 1:191–203.
  • Fields PR, Studier MH, Diamond H, Mech JF, Inghram MG, Pyle GL, Stevens CM, Fried S, Manning WM, Ghiorso A, et al. 1956. Transplutonium elements in thermonuclear test debris. Phys Rev. 102:180–182.
  • Fowler JF, Morgan RL. 1963. Pre-therapeutic experiments with the fast neutron beam from the Medical Research Council cyclotron. VIII. General review. Br J Radiol. 36:115–121.
  • Friedrich T, Ilicic K, Greubel C, Girst S, Reindl J, Sammer M, Schwarz B, Siebenwirth C, Walsh DWM, Schmid TE. 2018. DNA damage interactions on both nanometer and micrometer scale determine overall cellular damage. Sci Rep. 8:16063.
  • Frisch OR. 1939. Physical evidence for the division of heavy nuclei under neutron bombardment. Nature. 143:276.
  • Fry RJM, Storer JB. 1987. External radiaton carcinogenesis. Adv Radiat Biol. 13:31–90.
  • Garty G, Xu Y, Elliston C, Marino SA, Randers-Pehrson G, Brenner DJ. 2017. Mice and the A-bomb: irradiation systems for realistic exposure scenarios. Radiat Res. 187:475–485.
  • Godwin JT, Farr LE, Sweet WH, Robertson JS. 1955. Pathological study of eight patients with glioblastoma multiforme treated with neutron-capture therapy using boron 10. Cancer. 8:601–615.
  • Golshanian M, Kasesaz Y. 2018. Investigation of deep-seated tumor treatment based on Tehran research reactor new boron neutron capture therapy facility. J Can Res Ther. DOI:10.4103/jcrt.JCRT_224_17.
  • Goodhead DT. 2006. Energy deposition stochastics and track structure: what about the target? Radiat Prot Dosimetry. 122:3–15.
  • Goodhead DT, Berry RJ, Bance DA, Gray P, Stedeford JBH. 1977. High energy fast neutrons from the Harwell variable energy cyclotron. I. Physical characteristics. Am J Roentgenol. 129:709–716.
  • Goodhead DT, Munson RJ, Thacker J, Cox R. 1980. Mutation and inactivation of cultured mammalian cells exposed to beams of accelerated heavy ions IV. Biophysical interpretation. Int J Radiat Biol. 37:135–167.
  • Goodhead DT, Thacker J, Cox R. 1979. Effectiveness of 0.3 keV carbon ultrasoft X-rays for the inactivation and mutation of cultured mammalian cells. Int J Radiat Biol. 36:101–114.
  • Gray LH, Conger AD, Ebert M, Hornsey S, Scott OCA. 1953. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol. 26:638–648.
  • Gray LH, Mottram JC, Read J, Spear FG. 1940. Some experiments upon biological effects of fast neutrons. Br J Radiol. 13:371–388.
  • Gray LH, Read J, Mottram JC. 1939. Comparison of lethal effect of fast neutrons and gamma-rays on the growing tips of broad bean roots. Nature. 144:478–479.
  • Green S. 1998. Developments in accelerator based boron neutron capture therapy. Radiat Phys Chem. 51:561–569.
  • Griffin TW. 1992. Fast neutron radiation therapy. Crit Rev Oncol Hematol. 13:17–31.
  • Hall EJ, Novak JK, Kellerer AM, Rossi HH, Marino S, Goodman LJ. 1975. RBE as a function of neutron energy I. Experimental observations. Radiat Res. 64:245–255.
  • Hall EJ, Rossi HH. 1975. The potential of californium-252 in radiotherapy. Preclinical measurements in physics and radiobiology. Br J Radiol. 48:777–790.
  • Hatanaka H, Urano Y. 1986. Eighteen autopsy cases of malignant brain tumors treated by boron-neutron capture therapy between 1968 and 1985. In: Hatanaka H, editor. Boron-neutron capture therapy for tumors. Niigata: Nishimura; p. 381–416.
  • Heilbronn L. 2015. Neutron properties and definitions. https://three.jsc.nasa.gov/articles/Heilbronn_Neutron_Supplement.pdf. Date posted: 2015 July 09.
  • Hendry JH, Baarli J, Bianchi M, Sullivan AH. 1979. The effect of a 600 MeV neutron beam on mouse bone marrow. Int J Radiat Biol Relat Stud Phys Chem Med. 35:393–397.
  • Henshaw PS, Riley EF, Stapleton GE. 1947. The biologic effects of pile radiations. Radiology. 49:349–360.
  • Holt PD. 1988. Biophysical interpretation of the response of Chinese hamster cells to 24 keV neutrons. Br J Radiol. 61:1142–1146.
  • Howard-Flanders P. 1958. Physical and chemical mechanisms in the injury of cells of ionizing radiations. Adv Biol Med Phys. 6:553–603.
  • Howard-Flanders P, Alper T. 1957. The sensitivity of microorganisms to irradiation under controlled gas conditions. Radiat Res. 7:518–540.
  • Hussey DH, Fletcher GH, Caderao JB. 1974. Experience with fast neutron therapy using the Texas A and M variable energy cyclotron. Cancer. 34:65–77.
  • Ililic K, Combs SE, Schmid TE. 2018. New insights in the relative radiobiological effectiveness of proton irradiation. Radiat Oncol. 13:6.
  • [IARC] International Agency for Research on Cancer. 2000. Ionizing radiation, Part 1: X- and gamma (γ)-radiation, and neutrons. IARC monographs on the evaluation of carcinogenic risks to humans. Vol 75. Lyon: International Agency for Research on Cancer.
  • [IARC] International Agency for Research on Cancer. 2012. A review of human carcinogens Part D: radiation. IARC monographs on the evaluation of carcinogenic risks to humans. Vol 100. Lyon: International Agency for Research on Cancer.
  • [ICRP] International Commission on Radiological Protection. 1951. Recommendations of the International Commission on Radiological Protection – Revised by the International Commission on Radiological Protection, London, 1950. Br J Radiol. 24:46–53.
  • [ICRP] International Commission on Radiological Protection. 1955. Recommendations of the International Commission on Radiological Protection (Revised December 1, 1954). Br J Radiol. Suppl 6, 1–92.
  • [ICRP] International Commission on Radiological Protection. 1962. Recommendations of the International Commission on Radiological Protection: As Amended 1959 and Revised 1962. https://doi.org/10.1016/S0074-27402880018-3 [Accessed 2018 Sept 17]:[74p]. http://journals.sagepub.com/doi/pdf/10.1016/S0074-27402880018-3
  • [ICRP] International Commission on Radiological Protection. 2003. Relative biological effectiveness (RBE), quality factor (Q), and radiation weighting factor (wR). ICRP Publication 92. Oxford: Pergamon. p. 39–47.
  • [ICRP] International Commission on Radiological Protection. 2007. The 2007 recommendations of the International Commission on Radiological Protection. Report 103. Oxford, UK: Elsevier.
  • International X-Ray and Radium Protection Commission. 1937. International recommendations for X-Ray and radium protection - Revised by the International X-Ray and Radium Protection Commission of the Fifth International Congress of Radiology. Chicago, September 1937. Br J Radiol. (leaflet), p. 1–6.
  • Ishigure N, Endo A, Yamaguchi Y, Kawachi K. 2001. Calculation of the absorbed dose for the overexposed patients at the JCO criticality accident in Tokai-mura. J Radiat Res. 43:S137–S148.
  • Jones DTL. 1999. Present status and future trends of heavy particle radiotherapy. In Baron E, Lieuvin M, editors. Proc 15th Int Conf cyclotrons and their applications. 1998 June 14–19 Caen (France). Bristol (UK): Institute of Physics; p. 13–20.
  • Jones DTL, Wambersie A. 2007. Radiation therapy with fast neutrons: a review. Nucl Instrum Meth Phys Res A. 580:522–525.
  • Jones B, Underwood TS, Carabe-Fernandez A, Timlin C, Dale RG. 2011. Fast neutron relative biological effects and implications for charged particle therapy. Br J Radiol. 84:S11–S18.
  • Juerß D, Zwar M, Giesen U, Nolte R, Kriesen S, Baiocco G, Puchalska M, van Goethem M-J, Manda K, Hildebrandt G. 2017. Comparative study of the effects of different radiation qualities on normal human breast cells. Radiat Oncol. 12:159.
  • Kellerer AM, Hall EJ, Rossi HH, Teedla P. 1976. RBE as a function of neutron energy II. Statistical Analysis. Radiat Res. 65:172–186.
  • Kramer K, Li A, Madrigal J, Sanchez B, Millage K, 2016. Monte Carlo modeling of the initial radiation emitted by a nuclear device in the National Capitol Region. Report DTRA-TR-13-045 (R1). Fort Belvoir (VA): Defense Threat Reduction Agency.
  • Kreiner AJ, Bergueiro J, Cartelli D, Baldo M, Castell W, Asoia JV, Padulo J, Sandin JCS, Igarzabal M, Erhardt J. 2016. Present status of accelerator-based BNCT. Rep Pract Oncol Radiother. 21:95–101.
  • Kronenberg A. 1991. Perspectives on fast-neutron mutagenesis of human lymphoblastoid cells. Radiat Res. 128:S87–S93.
  • Kruger PG. 1940. Some biological effects of nuclear disintegration products on neoplastic tissue. Proc Natl Acad Sci USA. 26:181–192.
  • Kuhne WW, Gersey BB, Wilkins R, Wu H, Wender SA, George V, Dynan WS. 2009. Biological effects of high-energy neutrons measured in vivo using a vertebrate model. Radiat Res. 172:473–480.
  • Laiakis EC, Wang Y-W, Young EF, Harken AD, Xu Y, Smilenov L, Garty G, Brenner DJ, Fornace AJ. 2017. Metabolic dysregulation after neutron exposures expected from an improvised nuclear device. Radiat Res. 188:21–34.
  • Laramore GE. 2012. Neutron radiotherapy: a different perspective. S Afr Med J. 102:269.
  • Laramore GE, Krall JM, Griffin TW, Duncan W, Richter MP, Saroja KR, Maor MH, Davis LW. 1993. Neutron versus photon irradiation for unresectable salivary gland tumors: final report of an RTOG-MRC randomized clinical trial. Radiation Therapy Oncology Group. Medical Research Council. Int J Radiat Oncol Biol Phys. 27:235–240.
  • Lawrence EO. 1937. The biological action of neutron rays. Radiology. 29:313–321.
  • Lawrence JH, Aebersold PC, Lawrence EO. 1936. Comparative effects of x-rays and neutrons on normal and tumor tissue. Proc Natl Acad Sci USA. 22:543–557.
  • Lawrence JH, Lawrence EO. 1936. The biological action of neutron rays. Proc Natl Acad Sci USA. 22:124–133.
  • Lea DE, Haines RB, Bretscher E. 1941. The bactericidal action of X-rays, neutrons and radioactive radiations. J Hyg (Lond). 41:1–16.
  • Ledney GD, Elliott TB, Harding RA, Jackson WE, III, Inal CE, Landauer MR. 2000. WR-151327 increases resistance to Klebsiella pneumoniae infection in mixed-field- and γ-photon-irradiated mice. Int J Radiat Biol. 76:261–271.
  • Lei X, Qian C-Y, Qing Y, Zhao K-W, Yang Z-Z, Dai N, Zhong Z-Y, Tang C, Li Z, Gu X-Q, Zhou Q., et al. 2011. Californium-252 brachytherapy combined with external-beam radiotherapy for cervical cancer: long-term treatment results. Int J Radiat Oncol Biol Phys. 81:1264–1270.
  • Littlefield LG, Joiner EE. 1978. Cytogenic follow-up studies in six radiation accident victims: 16 and 17 years post-exposure. In: Late biological effects of ionizing radiation. Vol.I. Vienna: International Atomic Energy Agency; p. 297–308.
  • Littlefield LG, McFee AF, Sayer AM, O'Neill JP, Kleinerman RA, Maor MH. 2000. Induction and persistence of chromosome aberrations in human lymphocytes exposed to neutrons in vitro and in vivo: implications of findings in ‘retrospective’ dosimetry. Radiat Prot Dosim. 88:59–65.
  • Liu H, Wang Q, Wan X, Jia X, Liu B, Wang C-K. 2014. Californium-252 neutron brachytherapy combined with external beam radiotherapy for esophageal cancer: long-term treatment results. Brachytherapy. 13:514–521.
  • Lloyd DC, Edwards AA, Prosser JSP, Finnon P, Moquet JE. 1988. In vitro induction of chromosomal aberrations in human lymphocytes, with and without boron 10, by radiations concerned in boron neutron capture therapy. Br J Radiol. 61:1136–1141.
  • Locher GL. 1936. Biological effects and therapeutic possibilities for neutrons. Amer J Roentgenol Radium Ther. 36:1–3.
  • Marshak A. 1942a. Relative effects of x-rays and neutrons on chromosomes in different parts of the resting stage. Proc Natl Acad Sci USA. 28:29–35.
  • Marshack A. 1942b. Effects of x-rays and neutrons on mouse lymphoma chromosomes in different stages of the nuclear cycle. Radiol. 39:621–625.
  • Maruyama Y, 1997. Californium-252 neutron brachytherapy. In: Nag S, editor. Principles and practice of brachytherapy. Armonk, NY: Futura Publishing Co; p. 33–58.
  • Maruyama Y, van Nagell JR, Yoneda J, Donaldson ES, Gallion HH, Powell D, Kryscio RJ. 1991. A review of californium-252 neutron brachytherapy for cervical cancer. Cancer. 68:1189–1197.
  • Matsufuji N, Kanai T, Kanematsu N, Miyamoto T, Baba M, Kamada T, Kato H, Yamada S, Mizoe J, Tsuji H. 2007. Specification of carbon ion dose at the National Institute of Radiological Sciences (NIRS). J Radiat Res. 48:A81–A86.
  • McLaughlin TP, Monahan SP, Pruvost NL, Frolov Ryazanov BG, Sviridov VI, 2000. A review of criticality accidents. 2000 Revision. Report LA-13638. Los Alamos (NM): Los Alamos National Laboratory.
  • [MRC] Medical Research Council Neutron Therapy Working Group. 1986. A comparative review of the Hammersmith (1971-75) and Edinburgh (1977-82) neutron therapy trials of certain cancers of the oral cavity, oropharynx, larynx and hypopharynx. Br J Radiol. 59:429–440.
  • Mill AJ, Harrison KG. 1988. The interpretation of dose calculations and cell-survival measurements for the boron neutron capture therapy of brain tumours with 24 keV neutrons. Br J Radiol. 61:1147–1154.
  • Mill AJ, Harvey JR, 1980. Reactor and accelerator based filtered neutron beams. In: Okamoto K, editor. INDC(NDS)-114/CT. Proceedings of the IAEA Consultants' Meeting on Neutron Source Properties. Debrecen, Vienna: International Atomic Energy Agency; p. 135–200.
  • Mill AJ, Morgan GR, Newman SM. 1994. Cell survival measurements in an argon aluminium and sulphur filtered neutron beam: a comparison with 24 keV neutrons and relevance to boron neutron capture therapy. Br J Radiol. 67:1008–1016.
  • Miyamaru H, Murata I, Ootera Y, Matsunaka M. 2008. Neutron emission profile of d-Be reaction with low-energy deuteron beam for accelerator neutron source. J Nucl Sci Tech. Suppl 5:58–61.
  • Moffitt GB, Stewart RD, Sandison GA, Goorley JT, Argento DC, Jevremovic T, Emery R, Wootton LS, Parvathaneni U, Laramore GE. 2018. Dosimetric characteristics of the University of Washington Clinical Neutron Therapy System. Phys Med Biol. 63:105008.
  • Mole RH, Temple DM. 1959. The DNA content of the small intestine as a quantitative measure of damage and recovery after whole body irradiation. Int J Radiat Biol. 1:28–42.
  • Morgan GR, Mill AJ, Roberts CJ, Newman S, Holt PD. 1988. The radiobiology of 24 keV neutrons: measurement of the relative biological effect free-in-air, survival and cytogenetic analysis of the biological effect at various depths in a polyethylene phantom and modification of the depth-dose profile by boron 10 for V79 Chinese hamster and HeLa cells. Br J Radiol. 61:1127–1135.
  • Morgan GR, Roberts CJ, Mill AJ, Holt PD. 1986. Inactivation of Chinese hamster V79/4(AH1) and HeLa cells by 24 keV neutrons. Int J Radiat Biol Relat Stud Phys Chem Med. 50:35–40.
  • [NBS] National Bureau of Standards 1957. Protection against neutron radiation up to 30 million electron volts. NBS Handbook 63. Washington: National Bureau of Standards.
  • [NCRP] National Council on Radiation Protection and Measurements. 1990. The relative biological effectiveness of radiations of different quality. NCRP Report 104. Bethesda (MD): National Council on Radiation Protection and Measurements.
  • Neary GJ. 1965. Chromosome aberrations and the theory of RBE 1. General considerations. Int J Radiat Biol Relat Stud Phys Chem Med. 9:477–502.
  • Neary GJ, 1968. The dependence of the biological effectiveness of radiation on physical factors of radiation quality, and the significance of such dependence. In: Ebert HG, editor. Proceedings of the symposium on microdosimetry; Nov 13-15, 1967. Ispra, Italy, Brussels: European Communities; p. 205–242.
  • Neary GJ, Evans HJ, Tonkinson SM, Williamson FS. 1959. The relative biological efficiency of single doses of fast neutrons and gamma-rays on Vicia faba roots and the effect of oxygen Part III. Mitotic Delay. Int J Radiat Biol. 1:230–240.
  • Neary GJ, Hulse EV, Mole RH. 1962. The relative biological efficiency of fast neutrons and gamma-rays for life-shortening in chronically irradiated CBA mice. Int J Radiat Biol. 4:239–248.
  • Neary GJ, Savage JRK. 1966. Chromosome aberrations and the theory of RBE II. Evidence from track-segment experiments with protons and alpha particles. Int J Radiat Biol. 11:209–223.
  • Neary GJ, Munson RJ, Mole RH, 1957. Chronic radiation hazards: an experimental study with fast neutrons. London: Pergamon Press.
  • Neary GJ, Preston RJ, Savage JRK. 1967. Chromosome aberrations and the theory of RBE III. Evidence from experiments with soft X-rays, and a consideration of the effects of hard X-rays. Int J Radiat Biol. 12:317–345.
  • Neary GJ, Savage JRK, Evans HJ, Whittle J. 1963. Ultimate maximum values of the RBE of fast neutrons and gamma-rays for chromosome aberrations. Int J Radiat Biol. 6:127–136.
  • Neary GJ, Tonkinson SM, Williamson FS. 1959. The relative biological efficiency of single doses of fast neutrons and gamma-rays on Vicia faba roots and the effect of oxygen Part I. Reduction of root growth. Int J Radiat Biol. 1:201–215.
  • Nowell PC, Cole LJ. 1959. Late effects of fast neutrons versus X-Rays in mice: nephrosclerosis, tumors, longevity. Radiat Res. 11:545–556.
  • Parodi K. 2018. The biological treatment planning evolution of clinical fractionated radiotherapy using high LET. Int J Radiat Biol. 94:752–755.
  • Perks CA, Mill AJ, Constantine G, Harrison KG, Gibson JAB. 1988. A review of boron neutron capture therapy (BNCT) and the design and dosimetry of a high-intensity, 24 keV, neutron beam for BNCT research. Br J Radiol. 61:1115–1126.
  • Podgoršak EB, 2016. Radiation physics for medical physicists. Switzerland: Springer.
  • Preston DL, Pierce DA, Shimizu Y, Cullings HM, Fujita S, Funamoto S, Kodama K. 2004. Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates. Radiat Res. 162:377–389.
  • Puck T, Marcus PI. 1955. A rapid method for viable cell titration and clone production with HeLa cells in tissue culture: the use of X-irradiated cells to supply conditioning factors. Proc Natl Acad Sci USA. 41:432–437.
  • Puck T, Marcus PI. 1956. Action of X-rays on mammalian cells. J Exp Med. 103:653–669.
  • Puck T, Morkovin D, Marcus PI, Cieciura SJ. 1957. Action of X-rays on mammalian cells II. Survival curves of cells from normal human tissues. J Exp Med. 106:485–500.
  • Qian S, Ye L, Tian Y-H, Wang L-G, Huang Z-P, Li F, Hou B, Song N, Chen J, Liu Y, et al. 2017. Californium-252 neutron brachytherapy combined with external pelvic radiotherapy plus concurrent chemotherapy for cervical cancer: a retrospective clinical study. Chin J Cancer. 36:24.
  • Raju MR. 1980. Heavy particle radiotherapy. New York: Academic Press.
  • Rambach WA, Cooper JAD, Alt HL, Vogel HH, Clark JW, Jordan DL. 1959. The effect of single and multiple doses of Co60 gamma-radiation and fission neutron radiation on the incorporation of Fe5 into the rat erythropoietic system. Radiat Res. 10:148–166.
  • Roberts CJ, Morgan GR, Holt PD. 1987. The production of chromosome aberration in Chinese hamster fibroblasts exposed to 24 keV neutrons. Int J Radiat Biol. 51:341–351.
  • Rogers C, Oldroyd GED. 2008. Fast neutron mutagenesis for functional genomics. In: Kahl G, Meksem K, editors. The handbook of plant functional genomics. Weinheim: Wiley-VCH; p. 291–306.
  • Russell WL, Liane B, Russell LB, Kimball AW. 1954. The relative effectiveness of neutrons from a nuclear detonation and from a cyclotron in inducing dominant lethals in the mouse. Amer Natur. 88:269–286.
  • Rutherford E. 1920. Bakerial lecture: nuclear constitution of atoms. Proc Roy Soc A. 97:374–400.
  • Schaub SK, Stewart RD, Sandison GA, Arbuckle T, Liao JJ, Laramore GE, Zeng J, Rengan R, Tseng YD, Mayr NA, et al. 2018. Does neutron radiation therapy potentiate an immune response to Merkel cell carcinoma? Int J Part Ther. 5:183–195.
  • Schlea CS, Stoddard DH. 1965. Californium isotopes proposed for intracavity and interstitial radiation therapy with neutrons. Nature. 206:1058–1059.
  • Schmid E, Schlegel D, Guldbakke S, Kapsch R-P, Regulla D. 2003. RBE of nearly monoenergetic neutrons at energies of 36 keV-14.6 MeV for induction of dicentrics in human lymphocytes. Radiat Environ Biophys. 42:87–94.
  • Schmid E, Wagner FM, Canella L, Romm H, Schmid TE. 2013. RBE of thermal neutrons for induction of chromosome aberrations in human lymphocytes. Radiat Environ Biophys. 52:113–121.
  • Shu QY, editor. 2009. Induced plant mutations in the genomics era. Rome: Food and Agriculture Organization of the United Nations.
  • Slatkin DN. 1991. A history of boron neutron capture therapy of brain tumours: postulation of a brain radiation dose tolerance limit. Brain. 114:1609–1629.
  • Snell GD, Aebersold PC. 1937. The production of sterility in male mice by irradiation with neutrons. Proc Natl Acad Sci USA. 23:374–378.
  • Spalding JF, Hawkins SB, Sayeg JA. 1958. Relative biological effect of 14-Mev neutrons with the broad bean root (Vicia faba) as a test system. Radiat Res. 9:548–551.
  • Spalding JF, Hawkins SB, Strang VG. 1958. The relative effectiveness of neutrons of 1.4-Mev and 14-Mev energies and gamma rays in the reduction of fertility in the male mouse. Radiat Res. 9:369–377.
  • Specht HM, Neff T, Reuschel W, Wagner FM, Kampfer S, Wilkens JJ, Petry W, Combs SE. 2015. Paving the road for modern particle therapy - what can we learn from the experience gained with fast neutron therapy in Munich? Front Oncol. 5:262.
  • Stapleton GE, Hollaender A, Martin FL. 1952. Mechansims of lethal and mutagenic action of ionizing radiation on Aspergillus terreus I. Relationship of relative biological effectiveness to ion density. J Cell Comp Physiol. 39:87–100.
  • Stone RS. 1948. Neutron therapy and specific ionization. Am J Roentgenol Radium Ther. 59:771–788.
  • Stone RS, Larkin JC. 1942. The treatment of cancer with fast neutrons. Radiology. 39:608–618.
  • Stone RS, Lawrence JH, Aebersold PC. 1940. A preliminary report on the use of fast neutrons in the treatment of malignant disease. Radiology. 35:322–327.
  • Storer JB, Harris PS, Furchner JE, Langham WH. 1957. The relative biological effectiveness of various ionizing radiations in mammalian systems. Radiat Res. 6:188–288.
  • Storer JB, Sanders PC. 1958. Relative effectiveness of neutrons for production of delayed biological effects I. Effect of single doses of thermal neutrons on life span of mice. Radiat Res. 8:64–70.
  • Straume T, Dobson RL, Kwan TC. 1987. Neutron RBEs and the radiosensitive target for mouse immature oocyte killing. Radiat Res. 111:47–57.
  • Straume T, Kwan TC, Goldstein LS, Dobson RL. 1991. Measurement of neutron-induced genetic damage in mouse immature oocytes. Mutat Res. 248:123–133.
  • Sumption N, Ainsbury L, Goodhead D, Hirama T, Akashi M, Monobe M, Ando K, Anderson R. 2011. High frequency of simple and complex chromosome aberrations detected in the Tokai-mura survivor four and five years after the 1999 criticality accident. J Radiat Res. 52:300–308.
  • Svensson H, Landberg T. 1994. Neutron therapy-the historical background. Acta Oncol. 33:227–231.
  • Thoday JM, Lea DE. 1942. The effects of ionizing radiations on the chromosomes of Tradescantia bracteata. A comparison between neutrons and X-rays. J Genet. 42:263–284.
  • Timoféeff-Ressovsky NW, Zimmer KG. 1938. Neutronenbestrahlungsversuche zur mutationsauslösung an Drosophila melanogaster. Naturwissenschaften. 26:362–365.
  • Tobias CA, Anger H, Lawrence JH. 1952. Radiological use of high energy deuterons and alpha particles. Amer J Roentgenol. 6:1–27.
  • Todd P. 1967. Heavy-ion irradiation of cultured human cells. Radiat Res. Suppl 7:196–207.
  • Ulinskas K, Janulionis E, Valuckas KP, Samerdokiene V, Atkocius V, Rivard MJ. 2016. Long-term results for stage IIIB cervical cancer patients receiving external beam radiotherapy combined with either HDR 252Cf or HDR 60Co intracavitary brachytherapy. Brachytherapy. 15:353–360.
  • [UNSCEAR] United Nations Scientific Committee on Effects of Atomic Radiation. 1977. Sources and effects of ionizing radiation. Report to the General Assembly, with annexes, Pub. E.77.IX.1. New York: United Nations.
  • [UNSCEAR] United Nations Scientific Committee on Effects of Atomic Radiation. 2000. UNSCEAR 2000 Report to the General Assembly, with scientific annexes. New York: United Nations.
  • [UNSCEAR] United Nations Scientific Committee on Effects of Atomic Radiation. 2010. UNSCEAR 2008 Report to the General Assembly with Scientific Annexes. New York: United Nations.
  • Van Buul PP. 1989. The induction by ionizing radiation of chromosomal aberrations in rhesus monkey pre-meiotic germ cells: effects of dose rate and radiation quality. Mutat Res Lett. 225:83–89.
  • Vogel HH, Jordan DL. 1959. The relative biological effectiveness of Co60 gamma rays and fission neutrons: lethal effects on the 4-day chick embryo. Radiat Res. 11:667–683.
  • Wagner FM, Kneschaurek P, Kastenmüller A, Loeper-Kabasakal B, Kampfer S, Breitkreutz H, Waschkowski W, Molls M, Petry W. 2008. The Munich fission neutron therapy facility MEDAPP at the research reactor FRM II. Strahlenther Onkol. 184:643–646.
  • Wagner FM, Loeper-Kabasakal B, Breitkreutz H. 2012. Neutron medical treatment of tumours — a survey of facilities. J Instrum. 7:C03041.
  • Wambersie A, Hendry J, Gueulette J, Gahbauer R, Pötter R, Grégoire V. 2004. Radiobiological rationale and patient selection for high-LET radiation in cancer therapy. Radiother Oncol. 73:S1–S4.
  • Wambersie A, Richard F, Breteau N. 1994. Development of fast neutron therapy worldwide. Radiobiological, clinical and technical aspects. Acta Oncol. 33:261–274.
  • Watanabe H, Kashimoto N, Kajimura J, Ishikawa M, Kamiya K. 2007. Tumor induction by monoenergetic neutrons in B6C3F1 mice. J Radiat Res. 48:205–210.
  • Wang C-K. 2012. Progress in californium-252 neutron brachytherapy. In: Kishi K, editor. Brachytherapy. Rijeka: InTech; p. 33–58.
  • Whiteside TL, Demaria S, Rodriguez-Ruiz ME, Zarour HM, Melero I. 2016. Emerging opportunities and challenges in cancer immunotherapy. Clin Cancer Res. 22:1845–1855.
  • Whiting PW. 1936. Dominant lethal genetic effects caused by neutrons. Science. 84:68.
  • Wierzbicki JG, Rivard MJ, Roberts W. 1996. Physics and dosimetry of 252Cf sources. In: Wierzbicki JG, editor. Proceedings of the NATO advanced workshop on califormium-252. Isotope for 21st century radiotherapy; April 24–27. Detroit (MI). Kluwer Academic Publishers, p. 25–83.
  • Xiong Y, Shan J, Liu J, Zhao K, Chen S, Xu W, Zhou Q, Yang MY, Lei X. 2017. Californium-252 neutron intracavity brachytherapy alone for T1N0 low-lying rectal adenocarcinoma: a definitive anal sphincter-preserving radiotherapy. Sci Rep. 7:40619.
  • Xu Y, Randers-Pehrson G, Turner HC, Marino SA, Geard CR, Brenner DJ, Garty G. 2015. Accelerator-based biological irradiation facility simulating neutron exposure from an improvised nuclear device. Radiat Res. 184:404–410.
  • Zhang W, Wang Q, Li T, Lv J, Liu H, Jia X, Liu B, Fan Y, Wang Y, Wang J. et al. 2017. External beam radiation and high-dose-rate brachytherapy for elderly patients with gastroesophageal junction adenocarcinoma. J Contemp Brachyther. 9:330–337.
  • Zhou Q, Tang C, Zhao K-W, Xiong Y-L, Chen S, Xu W-J, Lei X. 2016. Clinical assessment of 252Californium neutron intracavitary brachytherapy using a two-channel Y applicator combined with external beam radiotherapy for endometrial cancer. Clinics. 71:10–16.
  • Zimmer KG, Timoféeff-Ressovsky NW. 1939. Note on the biological effects of densely ionizing radiation. Phys Rev. 55:11.
  • Zirkle R. 1947. Components of the acute lethal action of slow neutrons. Radiology. 49:271–273.
  • Zirkle RE, Aebersold PC. 1936. Relative effectiveness of x-rays and fast neutrons in retarding growth. Proc Natl Acad Sci USA. 22:134–138.
  • Zirkle RE, Aebersold PC, Dempster ER. 1937. The relative biological effectiveness of fast neutrons and X-Rays upon different organisms. Cancer Res. 29:556–562.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.